• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 15 of 100
CommentaryIt’s time for facts in the PBM debate
By David JoynerApril 3, 2024
photo portrait of a middle aged man wearing a suit and tie
NewslettersJohnson & Johnson CIO says employee upskilling is key to transforming health care
By John KellApril 3, 2024
Pharmacies
Health‘This is an emergency’: Trade group warns nearly a third of all independent pharmacies will go extinct because of a CMS rule
By Maia Anderson, Healthcare Brew and Morning BrewMarch 30, 2024
An out-of-focus person is point to their left and is standing in front of a window with the red and white Walgreens 'W' on it.
RetailWalgreens’ frail quarter goes beyond the discretionary spending dips afflicting its competitors. It’s ‘just not very good at retailing,’ analyst says
By Sasha RogelbergMarch 29, 2024
CommentaryThe economics of antibiotics are broken and superbugs are on the rise–but a solution inspired by the subscription economy could save millions of lives
By Howard DeanMarch 28, 2024
HealthOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
By Madison Muller, Robert Langreth and BloombergMarch 28, 2024
LeadershipChina woos CEOs of Apple, chipmakers, pharma giants as geopolitical tensions mount: ‘The risk-reward has changed’
By BloombergMarch 23, 2024
CommentaryBayer CEO: Corporate bureaucracy belongs in the 19th century. Here’s how we’re fighting it
By Bill AndersonMarch 21, 2024
After testing new drug compounds that appear to mimic the physical benefits of exercise in rodents, scientists say a pill may someday be able to do the same in humans.
LifeAn exercise pill may soon offer the same benefits as a workout, scientists say
By Lindsey LeakeMarch 18, 2024
A man with glasses and a white lab coat stands in front of a glass wall in a medical research facility.
NewslettersHow AI turbocharged the development of a new drug and what it might mean for health care
By Diane BradyMarch 14, 2024
HealthFDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer’s drug
By Tom Murphy, Matthew Perrone and The Associated PressMarch 8, 2024
“Even though health insurance costs are the second-largest line item after payroll, CEOs don’t really understand it or know anything about it,” billionaire entrepreneur and Shark Tank investor Mark Cuban tells Fortune’s Lindsey Leake.
HealthMark Cuban’s $141K mistake: The Cost Plus Drugs cofounder says CEOs don’t understand health care coverage, and it’s costing them big
By Lindsey LeakeMarch 8, 2024
Photo of Bill Anderson
HealthBayer CEO compares the state of troubled pharma group to the time he fractured his leg skateboarding: ‘We’re badly broken in 4 places’
By Ryan HoggMarch 6, 2024
Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity.
RetailNovo Nordisk’s Wegovy and Ozempic boom saved Denmark’s GDP from a no-growth 2023—and will help double its expected growth this year, country’s largest bank says
By Niclas Rolander and BloombergMarch 5, 2024
The Mark Cuban Cost Plus Drug Company will begin manufacturing its own medications in Dallas this week, cofounder and CEO Dr. Alex Oshmyansky announced Monday, March 4, 2024.
HealthMark Cuban’s Cost Plus Drugs will begin manufacturing its own medications this week
By Lindsey LeakeMarch 4, 2024
1...
  • 13
  • 14
  • 15
  • 16
  • 17
...100
Most Popular
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’An image of a popular article
By Emma BurleighFebruary 2, 2026
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House postAn image of a popular article
By Eleanor PringleFebruary 4, 2026
Investing
Tech stocks go into free fall as it dawns on traders that AI has the ability to cut revenues across the boardAn image of a popular article
By Jim EdwardsFebruary 4, 2026
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.